News
Softbox donates thermal covers for safe delivery of vital medicines to the Democratic Republic of the Congo
Softbox, a leading global innovator and provider of temperature control packaging systems and thermal covers for the life science and logistics industries, has helped protect temperature-sensitive shipments of essential medicines to the Democratic Republic of the Congo (DRC) in...
News
Cambridge University aims for autumn coronavirus vaccine trials after UK funding
The University of Cambridge is aiming to start clinical trials of its possible coronavirus vaccine in the autumn after it received 1.9 million pounds ($2.5 million) in funding from the British government, the university said. The scientists behind the...
Clinical Trials
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in India
Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started with the first patients screened by Bharati Vidyapeeth Deemed University (BVDU) Medical College and Hospital in Pune.
We have screened some patients. Tomorrow, we will...
Clinical Trials
Australian COVID-19 vaccine shows promising results in animal trials
A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes for its potential effectiveness and manufacturability, the varsity said on Wednesday.
According to the yet-to-be published...
News
India, Russia in talks over Covid vaccine production
The Russian vaccine, called Sputnik V, was the first to be approved for use anywhere in the world even though it is yet to undergo safety and efficacy trials large groups of human volunteers – one of the most...
News
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
Cryoport, Inc., a global leader in temperature-controlled supply chain solutions for the life sciences industry, announced it has signed an agreement to acquire MVE Biological Solutions, a global leader in manufactured vacuum insulated products and cryogenic freezer systems for...
News
Pfizer and BioNTech Share Positive Early Data on Lead mRNA Vaccine Candidate BNT162b2 Against COVID-19
Pfizer Inc. and BioNTech SE shared additional Phase 1 safety and immunogenicity data from their ongoing U.S. study of the BNT162 mRNA-based vaccine program against SARS-CoV-2, which has advanced into Phase 2/3 evaluation. The newly released manuscript describes key...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
